Search

Displaying results 4441 - 4450 of 10000 in total
  1. Drug

    Cariporide

    go.drugbank.com/drugs/DB06468
    Experimental

  2. Drug

    Tocopherylquinone

    go.drugbank.com/drugs/DB14094
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  3. Drug

    Morin

    go.drugbank.com/drugs/DB16770
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  4. Drug

    3,4-Dihydroxybenzoic Acid

    go.drugbank.com/drugs/DB03946
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  5. Drug

    Eflepedocokin alfa

    go.drugbank.com/drugs/DB16366
    Investigational

    Eflepedocokin alfa is a recombinant IL-22-Fc fusion protein manufactured in Chinese hamster ovary cells that is composed of 2 human interleukin 22 (IL-22) molecules linked to an immunoglobulin constant … [A225706, L27661] It is being developed by Evive Biotech (previously known as Generon BioMed Inc).[L27666]

    Synonyms: IL-22 DIMER F-652, IL-22 fusion protein
  6. Drug

    Refametinib

    go.drugbank.com/drugs/DB06309
    Investigational

  7. Drug

    Stamulumab

    go.drugbank.com/drugs/DB05915
    Investigational

    MYO-029 is a human anti-GDF-8 monoclonal antibody, which is being developed to treat muscle-wasting diseases including muscular dystrophy and age-related sarcopenia.

  8. Drug

    Bevirimat

    go.drugbank.com/drugs/DB06581
    Investigational

    Bevirimat, also known as PA-457 or YK-FH312, is investigated in clinical trials for treating HIV infection. Bevirimat is a solid. … They also show profound effects on scalp and body hair in humans. Bevirimat targets the protein gag-pol polyprotein.

  9. Drug

    E-2012

    go.drugbank.com/drugs/DB05171
    Experimental

    E-2012 is a gamma secretase modulator that is being evaluated as a potential new treatment for Alzheimer's disease.

  10. Drug

    LX6171

    go.drugbank.com/drugs/DB05180
    Investigational

    LX6171 is an oral drug candidate that was generated by Lexicon medicinal chemists and is being developed to treat disorders characterized by cognitive impairment, such as Alzheimer's disease, schizophrenia